Importantly, we characterize the ability of infected cells to secrete TCEs targeting CEA, as well as TCE specificity and functionality from infected colorectal cancer cells, patient tumour samples, and spheroid models in the presence and absence of T cells. This evidence concerns the gene CEACAM5 and neoplasm.